Literature DB >> 27485202

Effect of evodiamine on the proliferation and apoptosis of A549 human lung cancer cells.

Li Lin1, Li Ren2, Liujing Wen3, Yu Wang4, Jin Qi5.   

Abstract

Evodia rutaecarpa is a plant, which has antitumor activity. Evodiamine is an alkaloid with antitumor activity present in E. rutaecarpa and has potential to be developed into a therapeutic antitumor agent. The present study investigated the effect of evodiamine on the proliferation of A549 human lung cancer cells and the mechanism underlying these effects. The results indicated that evodiamine significantly inhibited proliferation, induced apoptosis and the expression of reactive oxygen species, arrested the cell cycle, regulated the expression of Survivin, Bcl-2 and Cyclin B1, regulated the activity of caspase-3/8 and glutathione in tumor cells, and decreased the activity of AKT/nuclear factor‑κB (NF‑κB) and Sonic hedgehog/GLI family zinc finger 1 (SHH/GLI1) signaling pathways in A549 cells. In conclusion, the evodiamine-induced inhibition of the proliferation of A549 lung cancer cells may be attributable to its ability to promote oxidative injury in the cells, induce apoptosis, arrest the cell cycle and regulate the AKT/NF‑κB and SHH/GLI1 signaling pathways, subsequently controlling the expression of tumor‑associated genes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27485202     DOI: 10.3892/mmr.2016.5575

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  14 in total

1.  Evodiamine in combination with histone deacetylase inhibitors has synergistic cytotoxicity in thyroid carcinoma cells.

Authors:  Si Hyoung Kim; Jun Goo Kang; Chul Sik Kim; Sung-Hee Ihm; Moon Gi Choi; Seong Jin Lee
Journal:  Endocrine       Date:  2019-05-17       Impact factor: 3.633

2.  Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy.

Authors:  Sajad Fakhri; Seyed Zachariah Moradi; Akram Yarmohammadi; Fatemeh Narimani; Carly E Wallace; Anupam Bishayee
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

Review 3.  Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers.

Authors:  Munmun Panda; Surya Kant Tripathi; Gokhan Zengin; Bijesh K Biswal
Journal:  Cell Biol Toxicol       Date:  2022-09-23       Impact factor: 6.819

4.  Evodiamine Exerts an Anti-Hepatocellular Carcinoma Activity through a WWOX-Dependent Pathway.

Authors:  Che-Yuan Hu; Hung-Tsung Wu; Yu-Chu Su; Ching-Han Lin; Chih-Jen Chang; Chao-Liang Wu
Journal:  Molecules       Date:  2017-07-14       Impact factor: 4.411

5.  Evodiamine inhibits migration and invasion by Sirt1-mediated post-translational modulations in colorectal cancer.

Authors:  Peng Zhou; Xiao-Peng Li; Rong Jiang; Yi Chen; Xiao-Ting Lv; Xing-Xian Guo; Kuan Tian; De-Zhi Yuan; Yan-Wei Lv; Jian-Hua Ran; Jing Li; Di-Long Chen
Journal:  Anticancer Drugs       Date:  2019-07       Impact factor: 2.248

6.  Evodiamine Exerts Anticancer Effects Against 143B and MG63 Cells Through the Wnt/β-Catenin Signaling Pathway.

Authors:  Shengdong Yang; Jin Chen; Tao Tan; Nan Wang; Yanran Huang; Yuping Wang; Xiaohui Yuan; Ping Zhang; Jinyong Luo; Xiaoji Luo
Journal:  Cancer Manag Res       Date:  2020-04-28       Impact factor: 3.989

7.  Evodiamine, a Novel NOTCH3 Methylation Stimulator, Significantly Suppresses Lung Carcinogenesis in Vitro and in Vivo.

Authors:  Tao Su; Xia Yang; Jian-Hua Deng; Qiu-Ju Huang; Su-Chao Huang; Yan-Min Zhang; Hong-Ming Zheng; Ying Wang; Lin-Lin Lu; Zhong-Qiu Liu
Journal:  Front Pharmacol       Date:  2018-05-01       Impact factor: 5.810

Review 8.  Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives.

Authors:  Xu Hu; Dahong Li; Chun Chu; Xu Li; Xianhua Wang; Ying Jia; Huiming Hua; Fanxing Xu
Journal:  Int J Mol Sci       Date:  2018-10-30       Impact factor: 5.923

9.  Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells.

Authors:  Sun Tae Hwang; Jae-Young Um; Arunachalam Chinnathambi; Sulaiman Ali Alharbi; Acharan S Narula; Ojas A Namjoshi; Bruce E Blough; Kwang Seok Ahn
Journal:  Molecules       Date:  2020-03-13       Impact factor: 4.411

10.  Evodiamine Eliminates Colon Cancer Stem Cells via Suppressing Notch and Wnt Signaling.

Authors:  Hyejin Kim; Yeongji Yu; SeokGyeong Choi; Hani Lee; Jinsuh Yu; Jeong-Ho Lee; Woo-Young Kim
Journal:  Molecules       Date:  2019-12-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.